Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Nakaigawa

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Hinyokika Kiyo. Acta Urologica Japonica|February 1, 1996
[Study of twenty-three cases of pediatric testicular tumors]K Sano, N Nakaigawa, K Terashima
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 24, 2001
[Molecular genetic mechanism of the kidney cancer]N Nakaigawa, M Yao, T Kishida, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 1, 1996
[A case of aphallia]N Nakaigawa, K Terashima, M Adachi, et al.
Oncogene|June 29, 2000
Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative SrcN Nakaigawa, G Weirich, L Schmidt, et al.
Proteins|May 17, 2001
Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studiesM Miller, K Ginalski, B Lesyng, et al.
Biochemical and Biophysical Research Communications|May 6, 1996
Differential effects of overexpression of PKC alpha and PKC delta/epsilon on cellular E2F activity in late G1 phaseN Nakaigawa, S Hirai, K Mizuno, et al.
Molecular and Cellular Biology|August 4, 2001
Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathwayA Danilkovitch-Miagkova, A Miagkov, A Skeel, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 1997
Activating mutations for the met tyrosine kinase receptor in human cancerM Jeffers, L Schmidt, N Nakaigawa, et al.
The Journal of Pathology|February 27, 2007
Identification and characterization of Birt-Hogg-Dubé associated renal carcinomaT Murakami, F Sano, Y Huang, et al.
Oncogene|May 18, 1999
Novel mutations of the MET proto-oncogene in papillary renal carcinomasL Schmidt, K Junker, N Nakaigawa, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Hinyokika Kiyo. Acta Urologica Japonica|February 1, 1996
[Study of twenty-three cases of pediatric testicular tumors]K Sano, N Nakaigawa, K Terashima
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 24, 2001
[Molecular genetic mechanism of the kidney cancer]N Nakaigawa, M Yao, T Kishida, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 1, 1996
[A case of aphallia]N Nakaigawa, K Terashima, M Adachi, et al.
Oncogene|June 29, 2000
Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative SrcN Nakaigawa, G Weirich, L Schmidt, et al.
Proteins|May 17, 2001
Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studiesM Miller, K Ginalski, B Lesyng, et al.
Biochemical and Biophysical Research Communications|May 6, 1996
Differential effects of overexpression of PKC alpha and PKC delta/epsilon on cellular E2F activity in late G1 phaseN Nakaigawa, S Hirai, K Mizuno, et al.
Molecular and Cellular Biology|August 4, 2001
Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathwayA Danilkovitch-Miagkova, A Miagkov, A Skeel, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 1997
Activating mutations for the met tyrosine kinase receptor in human cancerM Jeffers, L Schmidt, N Nakaigawa, et al.
The Journal of Pathology|February 27, 2007
Identification and characterization of Birt-Hogg-Dubé associated renal carcinomaT Murakami, F Sano, Y Huang, et al.
Oncogene|May 18, 1999
Novel mutations of the MET proto-oncogene in papillary renal carcinomasL Schmidt, K Junker, N Nakaigawa, et al.
Pageof 1